ArticleTheranostics2019

Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.

Yuhao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.